Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.42 Analyst target: $5.12 Upside: 1116.15%
Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. The company is headquartered in La Jolla, California.
See the full interactive analysis & chart →Informational only — not investment advice.